Skip to content
Home/Companies/MedTech/PathXL
PA

PathXL

MedTech·United Kingdom·Exited 2016·Held 4yr

PathXL is a MedTech company, headquartered in United Kingdom.

Entry
2012
Hold
4yr
Exit
2016
Est. EV
–

Who owns PathXL?

PathXL was owned by Clarendon Fund Managers through Co-Fund NI (2012 vintage) from 2012 to 2016, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-08

Clarendon Fund Managers
Investor
Clarendon Fund Managers
Co-Fund NI · 2012 · VC

Key facts

HQUnited Kingdom
SectorMedTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2016

More from Co-Fund NI

Other portfolio companies in the same fund.

Aflo
Active
MedTechUnited Kingdom
Antennaware
Active
Deep TechUnited Kingdom
Automated Intelligence
Active
SoftwareUnited Kingdom
Blinky
Active
ConsumerUnited Kingdom
Bubblebum
Active
ConsumerUK
CADshare
Active
SoftwareUK

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Custom Surgical
Active
ZEISS VenturesGermany· 2026
Data refreshed weekly · Sourced from public filings